Patents/Assignees

GLAXOSMITHKLINE BIOLOGICALS SA

101 patents in portfolio

US11690862utility2023
Delivery of RNA to Trigger Multiple Immune Pathways
0 cites
US11690863utility2023
Delivery of RNA to Trigger Multiple Immune Pathways
0 cites
US11690864utility2023
Delivery of RNA to Trigger Multiple Immune Pathways
0 cites
US11690865utility2023
Delivery of RNA to Trigger Multiple Immune Pathways
0 cites
US11679149utility2023
Immunogenic Compositions
0 cites
US11679153utility2023
Methods for Inducing an Immune Response
0 cites
US11666534utility2023
Methods of Administering Lipid Formulations with Viral Immunogens
0 cites
US11654190utility2023
Immunogenic Composition
0 cites
US11655284utility2023
RSV F Protein Compositions and Methods for Making Same
0 cites
US11655475utility2023
Immunisation of Large Mammals with Low Doses of RNA
0 cites
US11649467utility2023
Chikungunya Virus Antigen Constructs
0 cites
US11638693utility2023
Vaccine for Eliciting Immune Response Comprising RNA Encoding an Immunogen and Lipid Formulations Comprising Mole Percentage of Lipids
0 cites
US11638694utility2023
Vaccine for Eliciting Immune Response Comprising Lipid Formulations and RNA Encoding Multiple Immunogens
0 cites
US11639370utility2023
Antigen Delivery Platforms
0 cites
US11633472utility2023
Compositions
0 cites
US11629181utility2023
RSV F Protein Compositions and Methods for Making Same
0 cites
US11596645utility2023
Delivery of RNA to Trigger Multiple Immune Pathways
0 cites
US11590243utility2023
Formulation
0 cites
US11591364utility2023
Saponin Purification
0 cites
US11571472utility2023
Immunogenic Combinations
0 cites

← PreviousPage 5 of 6Next →